Literature DB >> 5935357

The control of phosphate excretion in uremia.

E Slatopolsky, L Gradowska, C Kashemsant, R Keltner, C Manley, N S Bricker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5935357      PMCID： PMC292744          DOI： 10.1172/JCI105382

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  6 in total

1.  THE FUNCTIONAL ADAPTATION OF THE DISEASED KIDNEY. I. GLOMERULAR FILTRATION RATE.

Authors:  N S BRICKER; S KLAHR; R E RIESELBACH
Journal:  J Clin Invest       Date:  1964-10       Impact factor: 14.808

2.  HEMIBLADDER PREPARATIONS FOR EXPERIMENTAL INDIVIDUAL RENAL FUNCTION STUDIES.

Authors:  H S STURIM; L H LACKNER; J A REINKEMEYER
Journal:  Invest Urol       Date:  1965-01

3.  Elective subtotal parathyroidectomy for renal hyperparathyroidism.

Authors:  S W STANBURY; G A LUMB; W F NICHOLSON
Journal:  Lancet       Date:  1960-04-09       Impact factor: 79.321

4.  Observations on phosphate transport in experimental renal disease.

Authors:  E REISS; N S BRICKER; S W KIME; P A MORRIN
Journal:  J Clin Invest       Date:  1961-01       Impact factor: 14.808

5.  Chronic renal disease with secondary hyperparathyroidism.

Authors:  V E POLLAK; A F SCHNEIDER; G FREUND; R M KARK
Journal:  AMA Arch Intern Med       Date:  1959-02

6.  Phosphorus excretion in renal failure.

Authors:  R GOLDMAN; S H BASSETT
Journal:  J Clin Invest       Date:  1954-12       Impact factor: 14.808
  6 in total
  23 in total

Review 1.  FGF23 and PTH--double agents at the heart of CKD.

Authors:  Justin Silver; Mariano Rodriguez; Eduardo Slatopolsky
Journal:  Nephrol Dial Transplant       Date:  2012-03-23       Impact factor: 5.992

2.  [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].

Authors:  G Offermann; K Schaefer; A Schulz; G Delling
Journal:  Klin Wochenschr       Date:  1976-07-01

3.  Influence of dietary phosphorus on renal phosphate reabsorption in the parathyroidectomized rat.

Authors:  T H Steele; H F DeLuca
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

Review 4.  Biochemical consequences of chronic renal failure: a review.

Authors:  M R Wills
Journal:  J Clin Pathol       Date:  1968-09       Impact factor: 3.411

5.  Serum parathyroid hormone levels and renal handling of phosphorus in patients with chronic renal disease.

Authors:  M M Popovtzer; W F Pinggera; M P Hutt; J Robinette; C G Halgrimson; T E Starzl
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

Review 6.  [Pharmaceutical therapy of bone metabolism disorders in chronic kidney disease mineral bone disorder (CKD-MBD) with special respect to antiresorptive substances].

Authors:  G Lehmann; G Wolf
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

7.  A micropuncture study of renal phosphate transport in rats with chronic renal failure and secondary hyperparathyroidism.

Authors:  N Bank; W S Su; H S Aynedjian
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

Review 8.  Metabolic bone disease secondary to renal and intestinal disorders.

Authors:  F P Muldowney
Journal:  Calif Med       Date:  1969-05

9.  Control of phosphate excretion in uremic man.

Authors:  E Slatopolsky; A M Robson; I Elkan; N S Bricker
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

Review 10.  Hyperphosphatemia of chronic kidney disease.

Authors:  Keith A Hruska; Suresh Mathew; Richard Lund; Ping Qiu; Raymond Pratt
Journal:  Kidney Int       Date:  2008-04-30       Impact factor: 10.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.